HHS: Ibogaine for PTSD?

Yesterday, US Department of Health & Human Services secretary Robert F Kennedy Jr announced up to $4.9million to advance development of ibogaine as a potential treatment for post-traumatic stress disorder. The National Institute of Mental Health also published a $20million Notice of Funding Opportunity to study rapid-acting psychotropic interventional drugs, such as ketamine, esketamine, psilocybin, for serious mental illnesses.